Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 20, 2025

Primary Completion Date

January 31, 2029

Study Completion Date

December 31, 2029

Conditions

Parkinson Disease (PD)

Interventions

DRUG

PDR001

This drug was packaged into AAV9 capsids and delivered via bilateral stereotaxic injection into the subthalamic nucleus

Trial Locations (1)

RECRUITING

Ruijin hospital, Shanghai

All Listed Sponsors

lead

Ruijin Hospital

OTHER

NCT07157345 - Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease | Biotech Hunter | Biotech Hunter